Category Archives: Pr Newswire

GN to gradually wind-down its Elite and Talk product lines. Strong performance in the Hearing division to partly off-set the extraordinary impact from the gradual wind-down

Today, GN has decided to gradually wind-down its Elite and Talk product lines to further increase focus and resources on more attractive parts of GN’s business. As communicated at the Capital Market Day in May 2024, GN is striving to build leading businesses in attractive markets and by this grow with healthy margins and ensure […]

Essential Pharma reaches agreement with AGC Biologics for late phase clinical manufacturing of its immunotherapy candidate for the treatment of high-risk neuroblastoma

Essential Pharma reaches agreement with AGC Biologics for late phase clinical manufacturing of its immunotherapy candidate for the treatment of high-risk neuroblastoma Egham, UK and Copenhagen, Denmark – 11 June, 2024 – Essential Pharma, an international specialty pharma group focused on ensuring that patients have sustainable access to low volume, clinically differentiated, niche pharmaceutical products […]

ITC final initial determination Ruled in favor of Hugel (no violation of Section 337)

SEOUL, South Korea, June 11, 2024 /PRNewswire/ — Hugel Inc, a global total medical aesthetics company, announced that the Administrative Law Judge (ALJ) for its U.S. International Trade Commission(ITC) investigation issued an initial determination on June 10th (local time) finding that “there is no violation of Section 337” based on Medytox’s allegation of unfair practices […]

Global Registrational Phase III Study of Olverembatinib for the Treatment of Patients with SDH-Deficient GIST Approved by the China CDE

SUZHOU, China, and ROCKVILLE, Md., June 11, 2024 /PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that the Center for Drug Evaluation (CDE) of China’s National Medical Product Administration (NMPA) has approved a global registrational Phase III study […]

RSMC President’s Asia Tour: A Glimpse into the Future of Globalized Reproductive Industry

SAN DIEGO and IRVINE, Calif. and HONG KONG, June 11, 2024 /PRNewswire/ — On June 11, the President of the Reproductive Science Medical Center (RSMC) in the United States successfully concluded his visit to Asia. During the week-long trip, the President engaged in one-on-one meetings with guests from various regions, providing in-depth explanations of reproductive […]

Crinetics Pharmaceuticals Announces June 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, June 10, 2024 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on June 10, 2024, the Compensation Committee of Crinetics’ Board of Directors granted non-qualified stock option awards to purchase an aggregate of 158,000 shares of its common stock to nine new non-executive employees under the Crinetics Pharmaceuticals, Inc. 2021 […]

The Westin Surabaya Introduces the Next Generation Heavenly® Bed

SURABAYA, Indonesia, June 11, 2024 /PRNewswire/ — As a leading wellness brand in the world of hospitality, Westin Hotels & Resorts, which is part of the Marriott Bonvoy portfolio, launched the latest generation of Heavenly® Bed. In line with its goal of strengthening its tradition of providing guests with a deep and refreshing sleep experience, […]

GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen’s Iqirvo® for Primary Biliary Cholangitis

Ipsen’s Iqirvo® (elafibranor) 80 mg tablets receives U.S. FDA accelerated approval as a first-in-class treatment for Primary Biliary Cholangitis (PBC) First-ever drug developed in-house by GENFIT to achieve U.S. FDA’s approval GENFIT is eligible to receive a €48.7 million milestone payment from Ipsen upon the first commercial sale of Iqirvo in the U.S., as well […]

Leading Indonesian digital bank, Jenius chooses Perx to transform its customer engagement strategy

The bank’s new loyalty engagement strategy aims to drive maximum customer lifetime value through rewarding loyalty experiences, instant gratification, and gamified customer interactions The collaboration will enable Jenius from Bank BTPN to boost customer engagement with Perx Loyalty Engagement Platform SINGAPORE, June 11, 2024 /PRNewswire/ — PT Bank BTPN Tbk (Bank BTPN) is spearheading the […]